营收382亿!创新药“一哥”百济神州,全面扭亏

云掌财经
Mar 02

创新药行业,已逐步进入业绩兑现阶段。BD行情退潮后,创新药行业估值回归理性,以往单一热门管线被给予天价估值的现象明显减少。同时,跨国药企受市场环境变化影响,逐步收缩战线,对依赖BD预期的创新药企业形成一定压力。2月26日晚,百济神州发布2025年业绩快报。数据显示,2025年公司实现营业收入382.05亿元,同比增长40.4%;营业利润25.62亿元,同比实现扭亏;净利润14.22亿元,同比扭亏,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10